NPR's Richard Knox reports on Merck's decision to offer discounted AIDS drugs to developing countries. While the drug company has improved its image by dropping profit margins in these poorer markets, the move will have minimal effect on the high cost of comprehensive AIDS treatment.
Copyright 2001 NPR
